Cargando…
Phosphoproteomic comparison of Pik3ca and Pten signalling identifies the nucleotidase NT5C as a novel AKT substrate
To identify novel effectors and processes regulated by PI3K pathway activation, we performed an unbiased phosphoproteomic screen comparing two common events of PI3K deregulation in cancer: oncogenic Pik3ca mutation (Pik3ca(H1047R)) and deletion of Pten. Using mouse embryonic fibroblast (MEF) models...
Autores principales: | Moniz, Larissa S., Surinova, Silvia, Ghazaly, Essam, Velasco, Lorena Gonzalez, Haider, Syed, Rodríguez-Prados, Juan Carlos, Berenjeno, Inma M., Chelala, Claude, Vanhaesebroeck, Bart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216349/ https://www.ncbi.nlm.nih.gov/pubmed/28059163 http://dx.doi.org/10.1038/srep39985 |
Ejemplares similares
-
Both p110α and p110β isoforms of PI3K can modulate the impact of loss-of-function of the PTEN tumour suppressor
por: Berenjeno, Inma M., et al.
Publicado: (2012) -
Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling
por: Berenjeno, Inma M., et al.
Publicado: (2017) -
Cancer-Associated PIK3CA Mutations in Overgrowth Disorders
por: Madsen, Ralitsa R., et al.
Publicado: (2018) -
Phosphoproteomics data classify hematological cancer cell lines according to tumor type and sensitivity to kinase inhibitors
por: Casado, Pedro, et al.
Publicado: (2013) -
Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL
por: Tzoneva, Gannie, et al.
Publicado: (2013)